Biosignal: Collaboration with international company on agriculture applications
Evaluation for use in crop protection to be conducted over 9 months
Biosignal's compounds are primarily in demand for their unique activity against bacterial biofilms, however in trials at Biosignal the compounds have also demonstrated a high level of activity against fungi. Fungal and bacterial pathogens cause significant damage to field crops, and result in the spoiling of seeds in storage and in the ground prior to germination. The agricultural sector is actively seeking novel and environmentally friendly treatments to combat these problems.
"Strategically, Biosignal is targeting the application of its technology in five key areas; industrial, agricultural, consumer, therapeutics and medical devices. These areas are ultimately anticipated to be separate business units or entities, and this deal is a positive early step in our strategy to establish a dedicated agricultural business," said Professor Peter Steinberg, CEO of Biosignal. 'We anticipate further developments in this field over the course of the year".
The evaluation will be conducted over the next 9 months with results expected early in 2009. The agreement is non-exclusive.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.